原发性肝细胞癌患者红细胞超氧化物歧化酶及血浆丙二醛改变

Changes in the Serum MDA and the Blood Cell SOD of Primary Liver Cancer Patients

原发性肝细胞癌(HCC)患者33名,测定红细胞超氧化物歧化酶(SOD),血浆丙二醛(MDA)。结果发现:HCC患者,血浆MDA含量增高,SOD明显降低。结果表明,HCC病理过程中,脂质过氧化作用增加。

The Serum monlandlyhyde (MDA) and the rea blood cell superoxide dismutase (SOD) were measured in 33 primary liver cancer patients. The results showed: (t). The content level of the serum MDA increased in these patients. (2) . The SOD activity markedly decreased. These demonstrated that in the pathologic process of primary liver can- cer, lipid peroxidation reaction increased, which may be caused by chemistry carcinogin.